Creso Pharma Inc.


Company Logo

Company Overview

Creso Pharma Inc. is a developer of cannabis and hemp-based therapeutic, nutraceutical and lifestyle products with wide patient and consumer reach for human and animal health.

The company announced its intent to acquire Halucenex Life Science in early 2021, which is a life science development company focused on researching novel psychedelic compounds, developing and licensing psychedelic compounds for the pharmaceutical and nutraceutical markets, and conducting clinical trials on the medical benefits of psychedelic medicine. 

Halucenex operates a 6,000 sq. ft. medical facility in Windsor, Nova Scotia with six treatment rooms and a secure laboratory designed to perform psychedelic-assisted psychotherapy and clinical research.

Financial Highlights


Revenue (ttm)


Gross Profit (ttm)


Diluted EPS (ttm)

Management Team

Mr. Boaz Wachtel M.A., M.D., MBA
Co-Founder & Non-Exec. Chairman

Mr. Christopher Grundy
Chief Financial Officer

Mr. William Lay B.Com.
Group CEO, MD & Director

Dr. Gian Trepp
Commercial & Marketing Director

Ms. Micheline MacKay B.Sc., M.Sc., P.M.P.
MD & Exec. Director

Ms. Jodi Scott
Exec. Director & Pres of US Operations

Ms. Erlyn Saromines Dawson A.C.I.S., ACIS, AGIA, B.Com., BCom., GradDipACG
Joint Company Sec.

Mr. Winton William Willesee C.P.A., GAICD, MAICD, MCom
Joint Company Sec.

Dr. Simon H. W. Buckingham

Hon. Brian Walker
Strategic Consultant & Chair of Scientific Advisory Committee

Sign Up for Alerts

Receive an email alert every time a company announces a merger, capital raise or files for an IPO.

Company Profile




Key Highlights

Market Capitalization

Shares Outstanding

Shares Short (% of Float)

Insider Ownership